Cardiac Safety Simulator – Certara

Certara > Cardiac Safety Simulator

Certara Demonstrates Proof of Concept for its Virtual Twin™ Technology

PRINCETON, NJ – Feb. 27, 2018 – Certara today announced that it has published two papers demonstrating proof of concept for its Virtual Twin™ technology.

0 comments. Click here to read/write comments.

Topics:

Simulation of Pharmacokinetics of Amitriptyline and Nortriptyline and Their Common Effect on Human Cardiac Electrophysiology in Healthy Population

Read More

0 comments. Click here to read/write comments.

Topics:

Real Patients & Their Virtual Twins: A New Paradigm for Personalized Drug Safety Assessment

June 19, 2018 – In this webinar, Sebastian Polak, Nikunj Patel, and Mark Holbrook will introduce the Cardiac Safety Simulator (CSS) platform and explain how they developed a QSTS model for citalopram to serve as a “virtual twin” and help predict the likely occurrence of cardiotoxic events in real patients under different clinical conditions.

0 comments. Click here to read/write comments.

Topics:

MENU

Learn More LinkedIn Twitter Facebook Email Subscribe to the Blog